SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers
- SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.
- The investment round is led by Think.Health Ventures, with support from existing investors. Think.Health…